Basetrophy Group Holdings Limited (Basetrophy Group) has released its Monthly Return for the period ended 31 March 2026, disclosing stable share capital metrics across the board.

Key points:

1. Authorised Share Capital • The authorised share capital remained unchanged at 3.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 300.00 million.

2. Issued and Treasury Shares • Issued shares (excluding treasury shares) stood at 265.61 million, identical to the prior month. • No treasury shares were held or transferred; total treasury shares remain at zero. • Consequently, total issued share capital also held steady at 265.61 million shares.

3. Public Float Compliance • Basetrophy Group confirmed adherence to the Hong Kong Stock Exchange’s minimum public float threshold of 25% of issued shares.

4. Equity-linked Instruments and Other Arrangements • The company reported no movements in share options, warrants, convertibles, or other equity-linked arrangements during March 2026.

Overall, the March 2026 return indicates a month of capital stability for Basetrophy Group, with no issuance, repurchase, or cancellation activities and continued compliance with listing regulations governing public float.